AI assistant
Edwards Lifesciences Corp — Director's Dealing 2012
May 23, 2012
30042_dirs_2012-05-23_a14a6846-ba50-436c-9e41-aefca6aa7cb5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2012-05-21
Reporting Person: Verguet Patrick B (CVP, Europe)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-05-21 | Common Stock | M | 5000.0000 | $21.9550 | Acquired | 53260.0000 | Direct |
| 2012-05-21 | Common Stock | S | 5000.0000 | $83.8500 | Disposed | 48260.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-05-21 | Employee Stock Option (Right to Acquire) | $21.9550 | M | 5000.0000 | Disposed | 2013-05-10 | Common Stock (5000.0000) | Direct |
Footnotes
F1: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
F2: This transaction was executed in multiple trades at prices ranging from $83.85 to $83.88. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.